Criterios dermatoscópicos como predictores de ausencia de respuesta a tratamiento con imiquimod en carcinomas basocelulares superficiales

Aróstegui Aguilar, J; Hervella Garcés, Marcos; Yanguas Bayona, JI; Azcona Rodríguez, M; Martínez de Espronceda Ezquerro, I; Sarriugarte Aldecoa-Otalora, J.
An. sist. sanit. Navar ; 42(3): 303-307, sept.-dic. 2019. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-191786

Documentos relacionados

  1. [Dermoscopic signs as predictors of non-response to imiquimod treatment in superficial basal cell carcinoma].
  2. Mucosal side effects in patients treated with topical imiquimod-A scoping review of the literature.
  3. Real-life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry.
  4. A systematic review of observational management of cutaneous basal cell carcinoma.
  5. A multicentric study on dermoscopic patterns and clinical-dermoscopic-histological correlates of basal cell carcinoma in Indian skin.
  6. Sebaceoma on the nose mimicking basal cell carcinoma: Pitfalls of dermoscopy and reflectance confocal microscopy.
  7. Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients.
  8. Reply to: Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial".
  9. Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial".
  10. Dermoscopy and reflectance confocal microscopy-augmented characterization of pigmented micro-basal cell carcinoma (less than 2 mm diameter).